Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritis

C. G. Fenton, J. M. Webster, C. S. Martin, S. Fareed, C. Wehmeyer, H. Mackie, R. Jones, A. P. Seabright, J. W. Lewis, Y. C. Lai, C. S. Goodyear, S. W. Jones, M. S. Cooper, G. G. Lavery, R. Langen, K. Raza, R. S. Hardy*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number182
Pages (from-to)1-12
Number of pages12
JournalArthritis Research & Therapy
Volume21
DOIs
Publication statusPublished - 1 Aug 2019

Keywords

  • Polyarthritis
  • Glucocorticoids
  • Muscle wasting
  • Osteoporosis
  • TUMOR-NECROSIS-FACTOR
  • RHEUMATOID-ARTHRITIS
  • MINERAL DENSITY
  • VERTEBRAL DEFORMITIES
  • KAPPA-B
  • RISK
  • RECOMMENDATIONS
  • OSTEOPOROSIS
  • PREVALENCE
  • FRACTURES

Cite this

Fenton, C. G., Webster, J. M., Martin, C. S., Fareed, S., Wehmeyer, C., Mackie, H., Jones, R., Seabright, A. P., Lewis, J. W., Lai, Y. C., Goodyear, C. S., Jones, S. W., Cooper, M. S., Lavery, G. G., Langen, R., Raza, K., & Hardy, R. S. (2019). Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritis. Arthritis Research & Therapy, 21, 1-12. [182]. https://doi.org/10.1186/s13075-019-1962-3